Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Ferrlecit

Sodium Ferric Gluconate Complex

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Ferrlecit:

BioPortfolio Logo
BioTrends Releases Three Publications - TreatmentTrends(R): US Nephrology, TreatmentTrends(R): Renal Dietitians, and TreatmentTrends(R): Anemia Managers - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 5th November, 2009 BioTrends Research Group, Inc.
EXTON, Pa., Nov. 5 /PRNewswire/ -- BioTrends Research Group, Inc. released three syndicated Nephrology TreatmentTrendsĀ® publications offering comprehensive insight into the management of renal anemia
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook 29th July, 2009 Watson Pharmaceuticals, Inc.
Generic Segment Information Three Months Ended Six Months Ended June 30, June 30,
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) 21st May, 2009 Watson Pharmaceuticals, Inc.
- Bold and innovative marketing campaign will target women and highlight product's efficacy, ease of use and excellent tolerability - CORONA, Calif., May 21 /PRNewswire-FirstCall/ -- Watson
Watson Provides Update on Ferrlecit(R) Supply and Distribution Agreement 18th May, 2009 Watson Pharmaceuticals, Inc.
Watson to Market and Sell Ferrlecit(R) through December 31, 2009 CORONA, Calif., May 18 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days 8th May, 2009 Watson Pharmaceuticals, Inc.
- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data - CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO(TM) (silodosin), a new,

This page has been viewed 30 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Ferrlecit across BioPortfolio, or for Ferrlecit Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.